NEW YORK, NY, UNITED STATES - Apr 15, 2015 - Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that CTI Clinical Trial and Consulting Services (CTI), a therapeutically-focused, full-service contract research organization (CRO), is expanding its use of the Medidata Clinical Cloud® platform to improve operational efficiencies, data accessibility and decision-making processes for its clinical trials
Therapeutic-Focused Global CRO Looks to
Medidata's Cloud-Based Solutions to Enhance Operational
Efficiencies, Data Accessibility and Decision Making
NEW YORK, NY, UNITED STATES - Apr 15, 2015 - Medidata (NASDAQ:
MDSO), the leading global provider of cloud-based solutions for
clinical research in life sciences, today announced that CTI
Clinical Trial and Consulting Services (CTI), a
therapeutically-focused, full-service contract research
organization (CRO), is expanding its use of the Medidata Clinical
Cloud® platform to improve operational efficiencies, data
accessibility and decision-making processes for its clinical
trials.
Were excited to continue building our partnership with
Medidata, said Kevin Schwarz, CTIs chief operating officer. By
streamlining trial operations, improving data input and output, and
providing better trial oversight, the Medidata platform allows us
to conduct faster, more insightful research-and ultimately help our
sponsors bring more effective therapies to the acutely ill patients
they serve.
Specializing in a number of emerging research areas-including
rare/orphan diseases, gene and stem cell therapy, transplantation,
immunology and other areas involving critically ill patient
populations-CTI offers a full spectrum of Phase I-IV clinical trial
services to pharmaceutical and biotechnology companies. To optimize
clinical trial processes, improve data accessibility and
efficiently track study progress, CTI has implemented Medidatas
integrated solutions for electronic data capture (
Medidata Rave®), clinical trial management (
Medidata CTMS) and medical coding (
Medidata Coder®).
Incorporating the Medidata platform in our clinical trials has
enabled our study teams to be much more productive, said Louis
Minham, senior director, information technology at CTI. As a
single source of truth, the unified platform lets us view
comprehensive trial information in one central location and be more
effective in how we extract, share and analyze data-allowing for
faster and smarter business decisions. We look forward to bringing
many more trials onto the platform in the near future.
A Medidata Services Partner since 2012, CTI has attained
accreditations in Rave, CTMS and Coder. The CROs dedication to
expanding its use of the Medidata Clinical Cloud further reinforces
CTIs commitment to overcoming critical cost, risk and efficiency
challenges throughout the clinical trial lifecycle, thus enabling
greater focus on providing therapeutic expertise to clients.
We are thrilled to be working with CTI, a world-class CRO
with unique and highly
specialized therapeutic expertise, said Medidatas SVP
of global partner business and program, Pat Bernard.
At Medidata we share CTIs mission of conducting high-quality
clinical research, and were proud that our innovative technology
is powering trials that benefit the lives of critically and
chronically ill patients.
Connect with Medidata:
About CTI Clinical Trial and Consulting
Services
CTI Clinical Trial and Consulting Services is an innovative,
international drug and device development organization that
delivers a full spectrum of clinical trial and consulting services
from bench to commercialization with a focus on immunology and a
passion for helping life-changing therapies succeed in chronically
and critically ill patient populations. CTIs focused therapeutic
approach provides pharmaceutical, biotechnology and startup firms
with clinical and disease area expertise from a unique mix of
academic, medical and industry specialists; rich intellectual
capital in transplantation, immunology, infectious diseases,
hematology, cardiology, nephrology, hepatology, regenerative
medicine and rare diseases; flexible study designs that accelerate
development programs and deliver high approval ratings that are
among the best in the industry; and exceptional global project
management and gold standard safety and data management systems
that strengthen their programs success potential. Established in
1999 and headquartered in Cincinnati, OH; CTI has offices in North
America, Europe, Latin America and Pac-Asia. For additional
information, please visit www.ctifacts.com.
Media Contact: Allison Schroeder, CTI
Clinical Trial and Consulting Services, 513-598-9290,aschroeder@ctifacts.com
About Medidata Solutions
Medidata is
the leading global provider of cloud-based solutions for clinical
research in life sciences, transforming clinical development
through its advanced applications and intelligent data analytics.
The Medidata Clinical Cloud® brings new levels of productivity and
quality to the clinical testing of promising medical treatments,
from study design and planning through execution, management and
reporting. We are committed to advancing the competitive and
scientific goals of global customers, which include over 90% of the
top 25 global pharmaceutical companies; innovative biotech,
diagnostic and device firms; leading academic medical centers; and
contract research organizations.
Investor Contact: Hulus
Alpay, Medidata Solutions, 212-419-1025, halpay@mdsol.com
Media Contact: Nicole Pariser, Medidata
Solutions, 212-659-1069, npariser@mdsol.com